- You can view the full Visa Ratings Report.
- Use our diversified services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Visa ( V) pushed the Diversified Services industry lower today making it today's featured Diversified Services laggard. The industry as a whole closed the day up 0.6%. By the end of trading, Visa fell $14.43 (-7.5%) to $177.01 on heavy volume. Throughout the day, 22,471,954 shares of Visa exchanged hands as compared to its average daily volume of 3,110,200 shares. The stock ranged in price between $170.99-$194.90 after having opened the day at $193.74 as compared to the previous trading day's close of $191.44. Other companies within the Diversified Services industry that declined today were: SmartPros ( SPRO), down 8.5%, Furiex Pharmaceuticals ( FURX), down 7.6%, Hudson Global ( HSON), down 7.1% and LivePerson ( LPSN), down 7.0%. Visa Inc., a payments technology company, engages in the operation of retail electronic payments network worldwide. It facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. Visa has a market cap of $98.8 billion and is part of the financial sector. Shares are up 26.3% year to date as of the close of trading on Tuesday. Currently there are 21 analysts that rate Visa a buy, no analysts rate it a sell, and 10 rate it a hold. TheStreet Ratings rates Visa as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
